U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz announced federal actions to combat healthcare fraud last Tuesday [1, 2].
These measures aim to protect citizens from fraudulent health claims and scams that can jeopardize patient safety and drain public resources. By targeting deceptive health products, the administration seeks to increase transparency in the medical marketplace.
The news conference took place on July 16, 2026, in the Department of Health and Human Services press briefing room in Washington, D.C. [1, 2]. The officials detailed enforcement strategies intended to curb the proliferation of misleading medical products and fraudulent billing practices within the healthcare system.
Secretary Kennedy and Dr. Oz focused on the need for stricter oversight of health-related marketing. They said the federal government will increase its efforts to identify and penalize entities that promote deceptive health products to the public [1, 2].
Dr. Oz, as the administrator of the Centers for Medicare and Medicaid Services, emphasized the role of federal agencies in safeguarding the integrity of government-funded healthcare. The initiative targets both the providers of fraudulent services, and the distributors of unverified health products [1, 2].
The briefing served as a public warning to companies and individuals engaging in medical scams. The administration said that new enforcement measures are now in place to protect Americans from these deceptive practices [1, 2].
“Federal actions aimed at combating health‑care fraud and deceptive health products.”
This coordinated effort between HHS and CMS signals a shift toward more aggressive federal policing of the wellness and medical product markets. By focusing on 'deceptive health products,' the administration is expanding its fraud-fighting scope beyond traditional insurance billing scams to include the regulation of health claims made directly to consumers.
